ABC Family Arquivos Brasileiros de Cardiologia International Journal of Cardiovascular Sciences ABC Heart Failure & Cardiomyopathy ABC Imagem Cardiovascular
Português English
ABC Family
Português English
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News

ABC Family

  • ABC Family
  • Arquivos Brasileiros de Cardiologia
  • International Journal of Cardiovascular Sciences
  • ABC Heart Failure & Cardiomyopathy
  • ABC Imagem Cardiovascular
Search in

No content found.

Journals
Ordering
Article types
Others

  1. Home
  2. Keyword: Heart Failure with Preserved Ejection Fraction
Figure 1
ABCHF
Review Article

Heart Failure with Preserved Ejection Fraction in Brazil: A Systematic Review

Edimar Alcides Bocchi et al. Andréa Araujo Brandão Evandro Tinoco Mesquita Juliana S. Nakamuta … André Valente Bichels Francisco José Forestiero

Abstract

Heart failure with preserved ejection fraction (HFpEF) is the most common condition of heart failure (HF) in patients over 65 years of age and is associated with high morbidity and mortality. Epidemiological data on this condition are still scarce in Brazil and these data are relevant for a better understanding of the impact and unmet needs in HFpEF and for the planning of actions to improve prevention, diagnosis, and treatment of this disease.

The objective of the study was to identify evidence on the epidemiology and clinical characteristics of Brazilian patients with HFpEF.

We systematically reviewed observational and clinical studies evaluating epidemiological and clinical data of Brazilian patients with HFpEF in the Pubmed/MEDLINE and LILACS databases, following PRISMA guidelines.

The prevalence of HFpEF in patients with confirmed HF ranged from 28.2 to 59.0% in the outpatient setting and from 20.0% to 53.1% in the hospital setting. Among patients with suspected HF, the prevalence of patients with LVEF>50% ranged from 29.0 to 37.6%. The most frequently reported comorbidities were systemic arterial hypertension and diabetes, with a prevalence of 57.4 to 100.0% in studies involving only patients with HFpEF, and from 10.2 to 49.1% in studies on patients with HF with normal ejection fraction (n = 14). Data on mortality and hospitalization rates were scarce.

Despite few and heterogeneous data on the prevalence of HFpEF in Brazil, the prevalence of this condition in primary care patients and in hospitalized patients was relatively high.

  • Comorbidity
  • Epidemiology
  • Heart Failure
  • Heart Failure with Preserved Ejection Fraction
  • Mortality
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
06/10/2023 DOI: 10.36660/abchf.20230033 Views 2
Figure 1
ABCHF
Review Article

Heart Failure with Preserved Ejection Fraction and Cancer

Antonio José Lagoeiro Jorge et al. Humberto Villacorta Luiz Claudio Danzmann Evandro Tinoco Mesquita

Abstract

Heart failure with preserved ejection fraction (HFpEF) is associated with high morbidity and mortality. After hospitalization for heart failure, the 5-year survival of HFpEF is 35%, which is worse than many forms of cancer. HFpEF and cancer share common risk factors. The use of chemotherapy medications such as anthracyclines is associated with increased aortic stiffness and diastolic dysfunction, suggesting that anthracycline therapy may increase the risk of HFpEF, given that worsening of diastolic function, which can be associated with the occurrence of HFpEF, is an early sign of cardiotoxicity. Radiotherapy, widely used in the treatment of breast cancer, leads to an increased risk of developing heart disease since radiation induces coronary microvascular endothelial damage and inflammation, leading to microvascular rarefaction, myocardial inflammation, oxidative stress, and fibrosis, which favor the development of HFpEF. Early diagnosis of cardiotoxicity is an important issue in the care of patients with cancer, and biomarkers have been extensively studied in predicting systolic dysfunction and heart failure with reduced ejection fraction, as well as in the development of HFpEF. HFpEF and cancer have an elevated prevalence, and they share age group, risk factors, and the pathophysiological phenomenon, in which inflammation plays a preponderant role. Biomarkers, especially natriuretic peptides, and ultrasound imaging are fundamental tools in the diagnostic detection and follow-up of these patients.

  • Cancer
  • Cardiotoxicity
  • Chemotherapy
  • Heart Failure with Preserved Ejection Fraction
  • Radiotherapy
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
18/12/2022 DOI: 10.36660/abchf.20220079 Views 1

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Bocchi EA, Brandão AA, Mesquita ET, Nakamuta JS, Bichels AV, Forestiero FJ. Heart Failure with Preserved Ejection Fraction in Brazil: A Systematic Review. ABC Heart Fail Cardiomyop 2023;3(3):e20230033.

Electronic Document Format (ABNT)

Bocchi, Edimar Alcides; Brandão, Andréa Araujo; Mesquita, Evandro Tinoco; Nakamuta, Juliana S.; Bichels, André Valente; Forestiero, Francisco José. Heart Failure with Preserved Ejection Fraction in Brazil: A Systematic Review. ABC Heart Fail Cardiomyop, v. 3, n. 3, e20230033, Oct. 2023.

Electronic Document Format (APA)

Bocchi, E. A., Brandão, A. A., Mesquita, E. T., Nakamuta, J. S., Bichels, A. V., & Forestiero, F. J. (2023). Heart Failure with Preserved Ejection Fraction in Brazil: A Systematic Review. ABC Heart Fail Cardiomyop, 3(3), e20230033.

Electronic Document Format (ISO)

Bocchi, Edimar Alcides and Brandão, Andréa Araujo and Mesquita, Evandro Tinoco and Nakamuta, Juliana S. and Bichels, André Valente and Forestiero, Francisco José. Heart Failure with Preserved Ejection Fraction in Brazil: A Systematic Review. ABC Heart Fail Cardiomyop [online]. 2023, vol. 3, n. 3, [cited 2026-10-14], e20230033. Available from: <https://journals.cardiol.br/en/article/heart-failure-with-preserved-ejection-fraction-in-brazil-a-systematic-review/>

EndNote RIS

Electronic Document Format (Vancouver)

Jorge AJL, Villacorta H, Danzmann LC, Mesquita ET. Heart Failure with Preserved Ejection Fraction and Cancer. ABC: Heart Failure & Cardiomyopathy 2022;2(4):343-5.

Electronic Document Format (ABNT)

Jorge, Antonio José Lagoeiro; Villacorta, Humberto; Danzmann, Luiz Claudio; Mesquita, Evandro Tinoco. Heart Failure with Preserved Ejection Fraction and Cancer. ABC: Heart Failure & Cardiomyopathy, v. 2, n. 4, p. 343-353, Dec. 2022.

Electronic Document Format (APA)

Jorge, A. J. L., Villacorta, H., Danzmann, L. C., & Mesquita, E. T. (2022). Heart Failure with Preserved Ejection Fraction and Cancer. ABC: Heart Failure & Cardiomyopathy, 2(4), 343-353.

Electronic Document Format (ISO)

Jorge, Antonio José Lagoeiro and Villacorta, Humberto and Danzmann, Luiz Claudio and Mesquita, Evandro Tinoco. Heart Failure with Preserved Ejection Fraction and Cancer. ABC: Heart Failure & Cardiomyopathy [online]. 2022, vol. 2, n. 4, [cited 2026-10-14], pp. 343-353. Available from: <https://journals.cardiol.br/en/article/heart-failure-with-preserved-ejection-fraction-and-cancer/>

  • About ABC Family
  • Internal Regulation
  • Editorial Board
  • Brazilian Society of Cardiology (SBC)

Issues

SBC Guidelines

  • Videos
  • Podcasts
  • News